1I30 | Oxidoreductase | date | Feb 12, 2001 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | E. Coli Enoyl Reductase +Nad+Sb385826 | ||||||||||||||
authors | M.A.Seefeld, W.H.Miller, D.J.Payne, C.A.Janson, X.Qiu | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Enoyl-[Acyl-Carrier-Protein] Reductase [Nadh] Chain: A, B Synonym: Enoyl-Acp Reductase Ec: 1.3.1.9 Engineered: Yes |
Organism_scientific: Escherichia Coli Organism_taxid: 562 Expression_system: Escherichia Coli Expression_system_taxid: 562 | ||||||||||||||
symmetry | Space Group: P 61 2 2 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.40 Å | ||||||||||||
ligand | 826, NAD | enzyme | Oxidoreductase E.C.1.3.1.9 BRENDA | ||||||||||||
related structures | by homologous chain: 1DFG, 1LXC | ||||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Inhibitors of bacterial enoyl acyl carrier protein reductase (FabI): 2,9-disubstituted 1,2,3,4-tetrahydropyrido[3,4-b]indoles as potential antibacterial agents., Seefeld MA, Miller WH, Newlander KA, Burgess WJ, Payne DJ, Rittenhouse SF, Moore TD, DeWolf WE Jr, Keller PM, Qiu X, Janson CA, Vaidya K, Fosberry AP, Smyth MG, Jaworski DD, Slater-Radosti C, Huffman WF, Bioorg Med Chem Lett. 2001 Sep 3;11(17):2241-4. PMID:11527706 |
Data retrieval |
View 1I30 in 3D |
Visual 3D analysis of 1I30 |
Structure-derived information |
- Domain d1i30a_, region A [Jmol] [rasmolscript] [script source] - Domain d1i30b_, region B [Jmol] [rasmolscript] [script source] |
Sequence-derived information |
Other resources with information on 1I30 |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |